Back to Blog

Comprehensive Vet Guide 2025: Toceranib (Palladia®) for Dogs & Cats – Targeted Cancer Therapy 🐾💊

  • 165 days ago
  • 12 min read

    In this article

Comprehensive Vet Guide 2025: Toceranib (Palladia®) for Dogs & Cats

Comprehensive Vet Guide 2025: Toceranib (Palladia®) for Dogs & Cats 🐾💊

Written by Dr Duncan Houston, BVSc – trusted veterinarian & founder of Ask A Vet 👨‍⚕️🐾

This comprehensive guide dives into toceranib phosphate (brand name Palladia®), the first FDA-approved oral targeted cancer therapy for dogs—and sometimes used in cats. Learn how it works, dosing, side effects, monitoring, safety measures, and how tools like Ask A Vet, Woopf & Purrz support your pet's cancer care journey. 🩺📘

1. What Is Toceranib & How It Works?

Toceranib is a multi-target tyrosine kinase inhibitor (TKI) that blocks tumor cell receptors and the growth of blood vessels feeding tumors—starving cancer cells of nutrients and slowing progression. It represents a shift from traditional chemotherapy by targeting tumor biology directly :contentReference[oaicite:2]{index=2}.

2. Approved Uses & Off‑Label Applications

  • FDA-approved in dogs for non-resectable grade II or III mast cell tumors, with or without lymph node involvement :contentReference[oaicite:3]{index=3}.
  • Off‑label uses include gastrointestinal stromal tumors (GISTs), carcinomas (anal sac, thyroid, nasal, bladder), hemangiosarcoma, osteosarcoma, HSA, and cancers in cats like mast cell and select carcinomas :contentReference[oaicite:4]{index=4}.

3. Dosing & Administration

Dogs: Standard dose is 3.25 mg/kg every other day, tablet form—10 mg (blue), 15 mg (orange), or 50 mg (red) strengths :contentReference[oaicite:5]{index=5}. Cats may receive lower or modified doses under oncologist oversight.

Tablets should be given whole, with or without food, and handled carefully—gloves recommended due to safety concerns :contentReference[oaicite:6]{index=6}.

If you miss a dose, don’t double up—contact your vet to reschedule :contentReference[oaicite:7]{index=7}.

4. Safety Precautions & Pet Parent Protection

  • Wear disposable gloves when handling tablets, pet waste (urine/feces), or saliva—it’s hazardous to humans, especially pregnant women :contentReference[oaicite:8]{index=8}.
  • Dispose of waste and litter securely, per veterinary guidance :contentReference[oaicite:9]{index=9}.
  • Pause use 3 days before surgery and delay restarting for up to 2 weeks due to wound healing and bleeding risks :contentReference[oaicite:10]{index=10}.

5. Side Effects & When to Call the Vet

Common side effects in dogs (in ~20–25%): diarrhea, vomiting, decreased appetite, lethargy, weight loss, lameness, and dark stools :contentReference[oaicite:11]{index=11}.

Bone marrow suppression—neutropenia and thrombocytopenia—can occur; rarer signs include proteinuria, hypertension, liver enzyme elevation, bleeding, pancreatitis, dermatologic or cardiac issues :contentReference[oaicite:12]{index=12}.

Side effects in cats are similar—reports indicate 20–70% may experience appetite loss, GI signs, or bone marrow changes :contentReference[oaicite:13]{index=13}.

Alert your vet if you notice: persistent vomiting/diarrhea, blood in stool/vomit, pale gums, weakness, lameness, swelling, or sudden weight loss.

6. Monitoring & Follow‑Up Protocol

Frequent visits are essential: initially at 1–2 weeks, then 2, 4, 6, 8 weeks, and every 6–12 weeks afterward :contentReference[oaicite:14]{index=14}. Each visit includes:

  • Physical exam and body weight
  • Complete blood count (CBC)
  • Biochemistry and urinalysis (with UPC if indicated)
  • Blood pressure
  • Tumor measurements via imaging or calipers :contentReference[oaicite:15]{index=15}.

7. Using Supportive Therapies

  • GI signs: antacids (famotidine/omeprazole), anti-nausea (maropitant/ondansetron), anti-diarrheals (loperamide/metronidazole) :contentReference[oaicite:16]{index=16}.
  • Bone marrow suppression: may require dose reduction or drug holiday; transfusions in severe cases :contentReference[oaicite:17]{index=17}.
  • Hypertension/proteinuria: treat with enalapril/amlodipine and monitor renal function :contentReference[oaicite:18]{index=18}.

8. Combination Protocols & Research

Palladia has been combined experimentally with vinblastine or chlorambucil, showing variable dosages (2.25–3.25 mg/kg EOD) and notable side effects like diarrhea and neutropenia—requiring careful dosing adjustments :contentReference[oaicite:19]{index=19}.

9. Contraindications

  • Do not use in dogs <2 years old, <3 kg, pregnant or nursing :contentReference[oaicite:20]{index=20}.
  • Avoid during active infections, unhealed wounds, or coagulopathies
  • Use cautiously in heart, liver, kidney disease unless closely monitored
  • Discuss all concurrent meds—NSAIDs, steroids, antifungals, and human chemo agents can increase toxicity risk :contentReference[oaicite:21]{index=21}.

10. Real‑Life Results & Owner Perspectives

Initial field trials showed ~60% response rate in mast cell tumors—tumor shrinkage or growth halt—and median survival benefits over standard care :contentReference[oaicite:22]{index=22}.

In retrospective studies, toceranib ± other therapies demonstrated 55–74% clinical benefit across various cancers, with some complete and partial remissions reported :contentReference[oaicite:23]{index=23}.

Owners appreciate that Palladia can be administered at home, targeting cancer while preserving quality of life, though some side effects require medication changes or supportive care.

11. FAQs

🐾 Can my pet stop Palladia if side effects occur?

Never stop without your vet’s guidance. Dose reductions or pauses can help manage side effects safely.

🐾 Is Palladia considered chemotherapy?

No—it's a targeted therapy (TKI), not traditional chemo. It works by blocking cancer growth pathways rather than killing fast-growing cells :contentReference[oaicite:24]{index=24}.

🐾 Can it be used in cats?

Yes, under veterinary oncologist supervision. Side effects are similar; careful dosing and monitoring are essential.

🐾 How long does treatment last?

As long as there’s tumor control and side effects are manageable. Regular rechecks ensure it remains beneficial.

12. Summary Table

Feature Details
Drug Class Oral tyrosine kinase inhibitor (TKI)
Main Use FDA‑approved for canine mast cell tumors; off-label in other cancers & cats
Dosing 3.25 mg/kg EOD (dogs); adjusted for cats
Side Effects GI upset, lethargy, bone marrow suppression, proteinuria, hypertension, weight loss, lameness
Monitoring CBC, chemistry, urinalysis, BP, imaging every few weeks
Contraindications Age <2 yrs, weight <3 kg, pregnancy, unhealed wounds, bleeding disorders
Handling Gloves required; avoid contamination; patient waste treated as biohazard

13. Final Thoughts from Dr Duncan

Toceranib (Palladia®) marks a major step forward in veterinary oncology—offering targeted, at-home cancer therapy. With correct dosing, consistent monitoring, and support from Ask A Vet, Woopf & Purrz, many pets maintain quality of life while battling cancer. Though potent, its side effects are manageable when veterinary support systems are in place. Stay close, stay informed—you’re giving your furry friend dedicated, compassionate care. 💗🐾


For dosing checks, side-effect support, and treatment tracking, visit AskAVet.com and download the Ask A Vet app. Your pet’s health and comfort matter—every day. 🐶📱🐱

Dog Approved
Build to Last
Easy to Clean
Vet-Designed & Tested
Adventure-ready
Quality Tested & Trusted
Dog Approved
Build to Last
Easy to Clean
Vet-Designed & Tested
Adventure-ready
Quality Tested & Trusted